Swiss startups raised CHF 2.95 billion across 354 financing rounds in 2025, according to the Swiss Venture Capital Report 2026, a 23.9% year-over-year increase and the first annual rise since 2022, decisively ending a two-year funding contraction.

Switzerland claimed the #1 position in the WIPO Global Innovation Index 2025 with a score of 66.0, extending an unbroken streak dating back to 2011. Sweden (62.6) and the United States (61.7) trailed by meaningful margins.

Haute Capital Partners SA (BX Swiss: HAUTE) is pleased to announce a strategic investment of CHF 500’000 in BioCopy AG (biocopy.com), a Swiss research-based biotechnology company headquartered in Basel, as part of the company’s capital increase.

Haute Capital Partners SA (BX Swiss: HAUTE) announces that Marcel Aellen is stepping down from the Board of Directors to retire, after several years of dedicated service.